Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Omnipaque 350
Total 0 results
Nothing found
Sponsors and Collaborators
Olynka Vega Vega
Centro Hospitalar de Lisboa Central EPE, Lisboa, Portugal
AdhereTech
Minnesota Medical Development, Inc.
The Danish Midwifery Organization
The Third People's Hospital of Hubei Province
Huan Wang, MD
NYC RING, Director
Eva Klappe
Academia Sinica, Taiwan
Ministry of Science and Technology of the People´s Republic of China
William Xu, MD
Klinik Bad Oexen, Germany
WuHui
Alaska Department of Health and Social Services
University Grants Committee, Hong Kong
Enrique Ordiñaga-Monreal, OD, MSc
Etwal Ltd.
Ataturk University SCIENTIFIC RESEARCH PROJECTS COORDINATION UNIT
Maryland Treatment Centers @ ARTC
View Full List
Medical Conditions
MET Alteration
Neuropathic Pain in Cancer
Substance Dependency
Gingival Recessions
Focus on Pain Regulation Mechanisms
Endotracheal Intubation Using Videolaryngoscope for General Anesthesia
Kidney Hypoxia
Smell Stimulation
Secondary Hypothyroidism
Near Infrared Imaging
Partial Seizures
Infarction, Middle Cerebral Artery
Congenital Aortic Stenosis
Atherosclerosis of the Peripheral Arteries
Regional Neuroblastoma
Moderate Epithelial Dysplasia
The Prevalance of HMPV After COVID-19 Pandemic
AIDS/HIV - RelatedDisease Associated With AIDS
Secondary Malignant Neoplasm of Other and Unspecified Sites
Hyper Bilirubinemia
View Full List
Drug Interventions
Ivermectin
Niacin
Vitamin D
DP001
YYC301-1 & YYC301-2 & YYC301-3
Extremecare
Cyclosporine 0.010%
SD-101
Peginterferon alfa-2a
2B3-101 50 mg/m2 every 3 weeks
Experimental drug: ESK-001
Peg-Interferon alpha-2b
Bempedoic Acid 180 MG Oral Tablet
Urokinase
Docetaxel Injection
PHA-022121 selected dose
Viread 300Mg Tablet
SOF/VEL
Neem plus propylene glycol plus salicylic acid
ASP8825
View Full List
CROs by country
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Burundi
Contract Research Organizations in Chile
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Estonia
Contract Research Organizations in Malawi
Contract Research Organizations in Mexico
Contract Research Organizations in Paraguay
Contract Research Organizations in Russia
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in Sri Lanka
Contract Research Organizations in Tanzania
CRO list by country
CROs in Uganda
SGS
ACROSS Global
MCT
Dokumeds
MRC/UVRI Uganda Research Unit
All CROs in Uganda
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe